Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003130276 | SCV003811206 | uncertain significance | Autosomal recessive spinocerebellar ataxia 2 | 2021-04-07 | criteria provided, single submitter | clinical testing | |
Neuberg Centre For Genomic Medicine, |
RCV003130276 | SCV004100628 | uncertain significance | Autosomal recessive spinocerebellar ataxia 2 | criteria provided, single submitter | clinical testing | The missense variant p.V367M in PMPCA (NM_015160.3) has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. The p.V367M variant is observed in 1/1,13,622 (0.0009%) alleles from individuals of European (Non-Finnish) background in gnomAD Exomes and is novel (not in any individuals) in 1000 Genomes. The p.V367M missense variant is predicted to be damaging by both SIFT and PolyPhen2.The valine residue at codon 367 of PMPCA is conserved in all mammalian species. The nucleotide c.1099 in PMPCA is predicted conserved by GERP++ and PhyloP across 100 vertebrates. For these reasons, this variant has been classified as Uncertain Significance. | |
Gene |
RCV004593214 | SCV005079488 | uncertain significance | not provided | 2024-05-02 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV004593214 | SCV005787868 | uncertain significance | not provided | 2024-06-02 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 367 of the PMPCA protein (p.Val367Met). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This missense change has been observed in individual(s) with clinical features of PMPCA-related conditions (external communication). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 2435094). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PMPCA protein function with a positive predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |